semaglutide
How One Clinic Unleashed Semaglutide Cost Paradox
In 2024, the clinic’s cost-benefit analysis revealed that semaglutide’s lower price does not automatically translate into better value, because tirzepatide’s higher efficacy can offset its greater cost when certain thresholds are reached. The paradox emerges when clinicians weigh drug price against long-term health savings for patients over